Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aducanumab Therapy to Treat Alzheimer’s Disease: A Narrative Review
Semira Abdi Beshir, Aadith Soorya, Affana Parveen, et al.
International Journal of Alzheimer s Disease (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

2024 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3708-3821
Open Access | Times Cited: 628
The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease
Emily Sun, Aishat Motolani, Leonardo Campos, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8972-8972
Open Access | Times Cited: 198
Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update
Golnaz Yadollahikhales, Julio C. Rojas
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 914-931
Open Access | Times Cited: 90
Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans
Hans Peter Grimm, Vanessa Schumacher, Martin Schäfer, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 45
Understanding neuropsychiatric symptoms in Alzheimer’s disease: challenges and advances in diagnosis and treatment
Andrew Pless, Destany Ware, Shalini Saggu, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 44
Neuroprotective and anti‐inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies
Elena Azzini, Sheila I. Peña‐Corona, Héctor Hernández‐Parra, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 3169-3189
Closed Access | Times Cited: 32
Alzheimer’s disease and its treatment–yesterday, today, and tomorrow
A. Y. Kim, Salman Al Jerdi, Ryan B. MacDonald, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 22
Review on anti-alzheimer drug development: approaches, challenges and perspectives
Abdallah E. Abdallah
RSC Advances (2024) Vol. 14, Iss. 16, pp. 11057-11088
Open Access | Times Cited: 20
Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
Young‐Ju Jang, Seong-Jun Kang, Hyun Su Park, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Donanemab: Appropriate use recommendations
G D Rabinovici, D. J. Selkoe, Suzanne E. Schindler, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100150-100150
Open Access | Times Cited: 2
Dietary Protection against Cognitive Impairment, Neuroinflammation and Oxidative Stress in Alzheimer’s Disease Animal Models of Lipopolysaccharide-Induced Inflammation
Davide Decandia, Francesca Gelfo, Eugenia Landolfo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5921-5921
Open Access | Times Cited: 28
The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases
Sarah E. Davis, Abagail B. Cirincione, Ana Catya Jiménez-Torres, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15340-15340
Open Access | Times Cited: 27
Mind Gaps and Bone Snaps: Exploring the Connection Between Alzheimer’s Disease and Osteoporosis
Hannah S. Wang, Sonali Karnik, Tyler J. Margetts, et al.
Current Osteoporosis Reports (2024) Vol. 22, Iss. 5, pp. 483-494
Open Access | Times Cited: 10
From the Mind to the Spine: The Intersecting World of Alzheimer’s and Osteoporosis
Tyler J. Margetts, Hannah S. Wang, Sonali Karnik, et al.
Current Osteoporosis Reports (2024) Vol. 22, Iss. 1, pp. 152-164
Open Access | Times Cited: 10
Interventions of cognitive impairment in older adults: A comprehensive review
Shivani Chib, Kajal Sharma, Randhir Singh
Aging and Health Research (2025), pp. 100223-100223
Open Access | Times Cited: 1
Molecular mechanisms in Alzheimer's disease and related potential treatments such as structural target convergence of antibodies and simple organic molecules
Nassima Oumata, Kui Lu, Yuou Teng, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114578-114578
Closed Access | Times Cited: 29
Symptoms and conventional treatments of Alzheimer's disease
Mehul R. Chorawala, Aayushi C. Shah, Aanshi J. Pandya, et al.
Elsevier eBooks (2024), pp. 213-234
Closed Access | Times Cited: 8
Nanocarriers-mediated nose-to-brain drug delivery: A novel approach for the management of Alzheimer’s disease
Abhishek Sonwani, Anchal Pathak, Keerti Jain
Journal of Drug Delivery Science and Technology (2024) Vol. 98, pp. 105855-105855
Closed Access | Times Cited: 8
Anti-amyloid Antibody Therapies for Alzheimer’s Disease
Kyung Won Park
Nuclear Medicine and Molecular Imaging (2024) Vol. 58, Iss. 4, pp. 227-236
Closed Access | Times Cited: 7
Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders
Sarfaraz K. Niazi, Zamara Mariam, Matthias Magoola
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6683-6683
Open Access | Times Cited: 6
Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
Anna Atlante, Giuseppina Amadoro, Valentina Latina, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6742-6742
Open Access | Times Cited: 23
Aducanumab: A new hope in Alzheimer's disease
Rouchan Ali, Ghanshyam Das Gupta, Pooja A. Chawla
Health Sciences Review (2022) Vol. 4, pp. 100039-100039
Closed Access | Times Cited: 19
Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer’s Disease
Ides M. Colin, Lidia W Szczepanski, A Gérard, et al.
touchREVIEWS in Endocrinology (2023) Vol. 19, Iss. 1, pp. 16-16
Open Access | Times Cited: 12
Aducanumab in Alzheimer’s Disease: A Critical Update
Sumel Ashique, Ekta Sirohi, Shubneesh Kumar, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 31, pp. 5004-5026
Closed Access | Times Cited: 12
Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer’s Disease
Jialin Li, Alireza Ebrahimi, Afia B. Ali
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5169-5169
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top